These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8258702)

  • 1. Class II MHC transcriptional mutants are defective in higher order complex formation.
    Riley JL; Boss JM
    J Immunol; 1993 Dec; 151(12):6942-53. PubMed ID: 8258702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes.
    Sloan JH; Hasegawa SL; Boss JM
    J Immunol; 1992 Apr; 148(8):2591-9. PubMed ID: 1560213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
    Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
    Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly of functional regulatory complexes on MHC class II promoters in vivo.
    Fontes JD; Jabrane-Ferrat N; Peterlin BM
    J Mol Biol; 1997 Jul; 270(3):336-45. PubMed ID: 9237901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells.
    Hasegawa SL; Riley JL; Sloan JH; Boss JM
    J Immunol; 1993 Mar; 150(5):1781-93. PubMed ID: 8436816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic complexity of regulatory mutants defective for HLA class II gene expression.
    Seidl C; Saraiya C; Osterweil Z; Fu YP; Lee JS
    J Immunol; 1992 Mar; 148(5):1576-84. PubMed ID: 1538137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective HLA DRA X box binding in the class II transactive transcription factor mutant 6.1.6 and in cell lines from class II immunodeficient patients.
    Stimac E; Urieli-Shoval S; Kempin S; Pious D
    J Immunol; 1991 Jun; 146(12):4398-405. PubMed ID: 1904083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A zinc finger protein that represses transcription of the human MHC class II gene, DPA.
    Scholl T; Stevens MB; Mahanta S; Strominger JL
    J Immunol; 1996 Feb; 156(4):1448-57. PubMed ID: 8568247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.
    Hasegawa SL; Boss JM
    Nucleic Acids Res; 1991 Nov; 19(22):6269-76. PubMed ID: 1956787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box.
    Ono SJ; Song Z
    J Biol Chem; 1995 Mar; 270(11):6396-402. PubMed ID: 7890777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells.
    Rigaud G; De Lerma Barbaro A; Nicolis M; Cestari T; Ramarli D; Riviera AP; Accolla RS
    J Immunol; 1996 Jun; 156(11):4254-8. PubMed ID: 8666795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental and cytokine-mediated regulation of MHC class II gene promoter occupancy in vivo.
    Kara CJ; Glimcher LH
    J Immunol; 1993 Jun; 150(11):4934-42. PubMed ID: 8496595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome.
    Moreno CS; Emery P; West JE; Durand B; Reith W; Mach B; Boss JM
    J Immunol; 1995 Nov; 155(9):4313-21. PubMed ID: 7594590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid nonlysosomal degradation of assembled HLA class II glycoproteins incorporating a mutant DR alpha-chain.
    Koppelman B; Cresswell P
    J Immunol; 1990 Oct; 145(8):2730-6. PubMed ID: 2212658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole.
    Montani V; Shong M; Taniguchi SI; Suzuki K; Giuliani C; Napolitano G; Saito J; Saji M; Fiorentino B; Reimold AM; Singer DS; Kohn LD
    Endocrinology; 1998 Jan; 139(1):290-302. PubMed ID: 9421427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The W element is a positive regulator of HLA-DRA transcription in various DR+ cell types.
    Cogswell JP; Austin J; Ting JP
    J Immunol; 1991 Feb; 146(4):1361-7. PubMed ID: 1991973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
    Wright KL; Ting JP
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA; Rimsza LM; Murphy SP
    Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes.
    Louis-Plence P; Moreno CS; Boss JM
    J Immunol; 1997 Oct; 159(8):3899-909. PubMed ID: 9378978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation-specific, octamer-dependent costimulation of kappa transcription.
    Liberg D; Sigvardsson M; Bemark M; Leanderson T
    J Immunol; 1998 Apr; 160(8):3899-907. PubMed ID: 9558096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.